Show simple item record

dc.contributor.authorVogel, C.
dc.contributor.authorChan, Arlene
dc.contributor.authorGril, B.
dc.contributor.authorKim, S.
dc.contributor.authorKurebayashi, J.
dc.contributor.authorLiu, L.
dc.contributor.authorLu, Y.
dc.contributor.authorMoon, H.
dc.date.accessioned2017-01-30T11:41:38Z
dc.date.available2017-01-30T11:41:38Z
dc.date.created2014-11-19T01:13:19Z
dc.date.issued2010
dc.identifier.citationVogel, C. and Chan, A. and Gril, B. and Kim, S. and Kurebayashi, J. and Liu, L. and Lu, Y. et al. 2010. Management of ErbB2-positive breast cancer: Insights from preclinical and clinical studies with lapatinib. Japanese Journal of Clinical Oncology. 40 (11): pp. 999-1013.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/14131
dc.publisherOxford University Press
dc.titleManagement of ErbB2-positive breast cancer: Insights from preclinical and clinical studies with lapatinib
dc.typeJournal Article
dcterms.source.volume40
dcterms.source.number11
dcterms.source.startPage999
dcterms.source.endPage1013
dcterms.source.issn0368-2811
dcterms.source.titleJapanese Journal of Clinical Oncology
curtin.accessStatusFulltext not available


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record